期刊文献+

他汀类药物应用于老年人群的研究进展 被引量:4

Statins therapy in the elderly: a review on treatment of dyslipidemia
下载PDF
导出
摘要 近年来,使用他汀类药物进行调脂治疗已成为防治心脑血管疾病的基本策略。然而,在老年患者中他汀类药物的处方率仍很低。目前,多项研究的亚组及荟萃分析证实他汀类药物可安全、有效地用于老年人群。本文对老年人血脂异常特点及2008年他汀类药物应用的研究进展进行综述。 In recent years, statins therapy is a basic strategy for prevention and treament of cardiovascular diseases.However, prescription rate of statins is still low in elderly. Subgroup data from recent clinical trials of statins and meta analysis indicate that the elderly patients are likely to derive the most benefits. In this review we evaluated the characteristics of dyslipidemia and the evidence for the use of statins in elderly individuals in 2008.
作者 刘梅林
出处 《世界临床药物》 CAS 2009年第3期153-156,181,共5页 World Clinical Drug
基金 中国医药卫生事业发展基金会资助项目
关键词 血脂异常 他汀类药物 不良反应 老年人 dyslipidemia statins adverse reaction elderly
  • 相关文献

参考文献10

  • 1Systematic Assessment of Vascular Risk(SAVR)Investigators.Suboptimal use of statin therapy in elderly patients with ath-erosclerosis:A population-based study[].Journal of Vascular Surgery.2008
  • 2Girman C J,Rhodes T,Mercuri M,et al.The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the air force/texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS)[].The American Journal of Cardiology.2004
  • 3Ettinger WH,Wahl PW,Kuller LH,et al.Lipoprotein lipids in older people: results from the Cardiovascular Health Study[].Circulation.1992
  • 4Shepherd J,Blauw GJ,Murphy MB,et al.Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial[].The Lancet.2002
  • 5Schwartz G G,Olsson A G,Ezekowitz M D,et al.Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial[].The Journal of The American Medical Association.2001
  • 6LaRosa JC,Grundy SM,Waters DD,et al.Intensive lipid lowering with atorvastatin in patients with stable coronary disease[].The New England Journal of Medicine.2005
  • 7Streja L,Packard CJ,Shepherd J, et al.Factors affecting low-densitylipoprotein and high-density lipoprotein cholesterol response to pravastatin in theWest Of Scotland Coronary Prevention Study (WOSCOPS)[].The American Journal of Cardiology.2002
  • 8Lindgren P,Buxton M,Kahan T, et al.Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo- Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)[].Eur J Cardiovasc Prev Rehabil.2005
  • 9RIDKER P M,DANIELSON E,FONSECA F A,etal.Rosuvastatinto prevent vascular events in men andwomen with elevated C-reactive protein[].The New England Journal of Medicine.2008
  • 10AFILALOJ,DUQUE G,STEELE R,et al.Statins for secondary prevention in elderly patients:a hierar-chical bayesian meta-analysis[].Journal of the American College of Cardiology.2008

同被引文献19

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部